Discovery of common and rare genetic risk variants for colorectal cancer
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome
sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants …
sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants …
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications
…, L Elbling, H Cantonati, J Attems, A Gsur… - Journal of cancer …, 2005 - Springer
Purpose The aim of this retrospective study was to comparatively investigate the expression
of the three drug-resistance genes P-glycoprotein (P-gp), multidrug-resistance protein 1 (…
of the three drug-resistance genes P-glycoprotein (P-gp), multidrug-resistance protein 1 (…
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
…, K Visvanathan, C Ulrich, E Siegel, S Brezina, A Gsur… - Nature …, 2023 - nature.com
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
[HTML][HTML] Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis
Physical activity has been associated with lower risks of breast and colorectal cancer in
epidemiological studies; however, it is unknown if these associations are causal or confounded. …
epidemiological studies; however, it is unknown if these associations are causal or confounded. …
[PDF][PDF] Genome-wide modeling of polygenic risk score in colorectal cancer risk
Accurate colorectal cancer (CRC) risk prediction models are critical for identifying individuals
at low and high risk of developing CRC, as they can then be offered targeted screening …
at low and high risk of developing CRC, as they can then be offered targeted screening …
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes
J Drach, A Gsur, G Hamilton, S Zhao, J Angerler… - 1996 - ashpublications.org
The physiological role of the multidrug resistance P-glycoprotein (P- gp), which is expressed
by normal human T lymphocytes, is still largely unknown. To investigate whether or not P-…
by normal human T lymphocytes, is still largely unknown. To investigate whether or not P-…
[HTML][HTML] Association analyses identify 31 new risk loci for colorectal cancer susceptibility
…, I Kirac, P Matošević, P Hofer, S Brezina, A Gsur… - Nature …, 2019 - nature.com
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, and has a
strong heritable basis. We report a genome-wide association analysis of 34,627 CRC cases …
strong heritable basis. We report a genome-wide association analysis of 34,627 CRC cases …
Novel common genetic susceptibility loci for colorectal cancer
…, WM Grady, JK Greenson, A Gsur… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Previous genome-wide association studies (GWAS) have identified 42 loci (P <
5 × 10 −8 ) associated with risk of colorectal cancer (CRC). Expanded consortium efforts …
5 × 10 −8 ) associated with risk of colorectal cancer (CRC). Expanded consortium efforts …
Cumulative burden of colorectal cancer–associated genetic variants is more strongly associated with early-onset vs late-onset cancer
Background & Aims Early-onset colorectal cancer (CRC, in persons younger than 50 years
old) is increasing in incidence; yet, in the absence of a family history of CRC, this population …
old) is increasing in incidence; yet, in the absence of a family history of CRC, this population …
Multiple Myeloma: High Incidence of Chromosomal Aneuploidy as Detected by Interphase Fluorescence in Situ Hybridization
…, F Rosenthal, M Fiegl, C Rothermundt, A Gsur… - Cancer research, 1995 - AACR
Because metaphase cytogenetic studies in multiple myeloma (MM) are hampered by a low
proliferative activity of myeloma cells in vitro, interphase cytogenetics by means of …
proliferative activity of myeloma cells in vitro, interphase cytogenetics by means of …
